Politics, profit, propaganda and public health: The four dimensions of vaping policy

Few questions in public health are as contested as what to do about e-cigarettes, and much of the conflict arises because four forces are at play, with three crowding out the one that matters most.

Politics concerns the political tensions: harm reduction set against precaution and abstinence, and the divergence between jurisdictions: Britain’s comparatively liberal, quit-aid framing and its moves on disposables and a generational sales ban; Australia’s prescription-only model; the American authorisation regime; and the perennial tension between protecting young people and helping adult smokers to stop.

Profit relates to the commercial determinants: the tobacco industry’s absorption of the category, the independent and disposables sectors, illicit supply, and the way the pursuit of margin shapes not only products (flavours, nicotine salts, devices engineered for appeal) but also the arguments advanced on every side.

Propaganda involves the systematic distortion of the evidence base, including the steady rise in the mistaken belief that vaping is as dangerous as smoking, the misattribution of the US EVALI outbreak, gateway rhetoric and youth moral panic, alongside the overclaiming of vaping’s champions.

Public health concerns what arguably should be the focus: what the evidence actually shows, and the fact that good policy here means minimising harm rather than allowing harm in the vain service of eliminating it.

This presentation will explore how, when politics, profit and propaganda are allowed to crowd out the public-health calculus, both smokers and non-smokers lose.